Ceryvyn Therapeutics Limited

A$0.01As of Sun 8 Nov 2026, 12:00 UTC
ASX:CYVHealthcare
Country Australia
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Biotechnology
Beta (5Y) 1.50
PE TTM 0.041
TSR TTM —
Mkt cap A$13.68M
ROIC (14.98%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0129
28.74%
(36.25%)
Buy 11|6|2|2|9
2Q26
3Q26
4Q26
1Q27
Earnings per share$
—
—
—
—
14.10%
17.25%
15.69%
25.64%
Revenue$M
1.777
1.851
1.958
1.943
1.91%
3.42%
11.87%
7.15%
Peers (US$9.395M)
Cap (US$)
PE
9.467M
—
8.797M
—
9.421M
—
Capital
TTM
5Y
10Y
Leveragex
0.882
(0.016)
(0.017)
EBIT/Intx
0.983
0.207
0.201
Own earn%
48.54
(148.65)
(126.68)
Sh yield%
44.92
31.28
34.56
Owners
Insiders/Inst%
9.35
35.67
Short interest%
5.68
SBC / revenue%
1.40
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
8–21
$1 testx
0.1
Incr. ROIC%
1